Q1 2025 Achieve Life Sciences Inc Earnings Call Transcript
Key Points
- Achieve Life Sciences Inc (ACHV) is on track to submit the NDA for cytisinicline next month, marking a significant milestone.
- Cytisinicline has shown excellent efficacy and tolerability in helping patients quit smoking and vaping, with promising results from the ORCA-3 clinical trial published in JAMA Internal Medicine.
- The ORCA-OL open-label study has over 100 patients with the FDA's required 1-year exposure to cytisinicline, demonstrating strong patient retention and tolerability.
- The company has convened a Scientific Advisory Board with leading experts, highlighting the excitement and potential of cytisinicline in treating nicotine dependence.
- Achieve Life Sciences Inc (ACHV) has a strong cash position of $23.2 million as of March 31, 2025, and is committed to financial discipline to support key priorities.
- Achieve Life Sciences Inc (ACHV) reported a net loss of $12.8 million for the first quarter of 2025, reflecting high operating expenses.
- The company faces the challenge of launching cytisinicline in a market that has not seen a new nicotine dependence drug in nearly 20 years.
- There is uncertainty regarding the exact timing of the commercial launch post-NDA approval, which could impact revenue projections.
- Achieve Life Sciences Inc (ACHV) is still in the process of finalizing its pricing and payer strategy, which could affect market access and reimbursement.
- The company has not yet secured strategic partnerships for potential comorbid COPD studies, which could provide additional non-dilutive capital.
Greetings. Welcome to Achieve Life Sciences first-quarter 2025 earnings conference call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to Nicole Jones, Achieve Investor Relations.
From Achieve Life Sciences, we are joined by Rick Stewart, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; and Mark Oki, Chief Financial Officer. The management team will be available for Q&A following the prepared remarks. As a reminder, a replay will be available later today by using the information provided in the earnings press release issued prior to this call or visiting the Achieve website. Today's conference call will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Achieve.
Although management believes these statements are reasonable based on estimates, assumptions and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
